These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 49053)

  • 1. Tumor-associated transplantation antigens in immune rejection of mouse malignant cell hybrids.
    Jami J; Ritz E
    Proc Natl Acad Sci U S A; 1975 Jun; 72(6):2130-4. PubMed ID: 49053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation of syngeneic tumor-specific immunity by semiallogeneic cell hybrids.
    Toffaletti DL; Darrow TL; Scott DW
    J Immunol; 1983 Jun; 130(6):2982-6. PubMed ID: 6189910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody-recognizing tumor-associated antigen of DBA/2 mouse lymphoma L1210 and its sublines.
    Fuji H
    Transplant Proc; 1980 Sep; 12(3):388-90. PubMed ID: 6784299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonmalignancy of hybrids derived from two mouse malignant cells. I. Hybrids between L1210 leukemia cells and malignant L cells.
    Jami J; Ritz E
    J Natl Cancer Inst; 1973 Nov; 51(5):1647-53. PubMed ID: 4762938
    [No Abstract]   [Full Text] [Related]  

  • 5. Common leukemia-associated antigen of DBA/2 mouse leukemia detected by tumor rejection and complement-dependent cytotoxicity assays.
    Kawashima K; Takeyama H; Takahashi T; Kato Y; Watanabe E; Suzuki H; Minam S; Isobe K; Yamada K; Ito Y
    Gan; 1979 Dec; 70(6):769-76. PubMed ID: 94022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serologically defined antigens on the surface of somatic hybrid cells.
    Rubio N
    Int Arch Allergy Appl Immunol; 1982; 67(2):123-6. PubMed ID: 7056591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L; Fuji H
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response to somatic cell hybrids between ultraviolet radiation-induced regressor and spontaneous progressor C3H mouse tumor cells.
    Chen PW; Kaba DS; Ananthaswamy HN
    Cancer Res; 1990 Mar; 50(5):1544-9. PubMed ID: 2137370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-host cell hybrids in radiochimeras.
    Wiener F; Fenyö EM; Klein G
    Proc Natl Acad Sci U S A; 1974 Jan; 71(1):148-52. PubMed ID: 4521047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
    Plata F; Jongeneel V; Cerottini JC; Brunner KT
    Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Afferent and efferent specificity in the induction and elicitation of parental cross-protective immunity by an immunogenic murine tumor variant: associative recognition of a unique tumor-specific antigen on somatic cell hybrids.
    LeGrue SJ; Ananthaswamy HN; Simcik WJ
    Cancer Res; 1989 Sep; 49(17):4747-51. PubMed ID: 2474372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonmalignancy of hybrids derived from two mouse malignant cells. II. Analysis of malignancy of LM (TK-) Cl 1D parental cells.
    Jami J; Ritz E
    J Natl Cancer Inst; 1975 Jan; 54(1):117-22. PubMed ID: 1113297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of malignancy in interspecies Chinese hamster X mouse cell hybrids.
    Barski G; Blanchard MG; Youn JK; Leon B
    J Natl Cancer Inst; 1973 Sep; 51(3):781-92. PubMed ID: 4355218
    [No Abstract]   [Full Text] [Related]  

  • 14. High-grade tumor-specific immunity induced by L1210 leukemia variants obtained from the culture of L1210 cells fused with Lesch-Nyhan fibroblasts.
    Kawashima K; Nagura E; Watanabe E; Mizoguchi K; Saga S; Isobe K; Nakashima I; Yamada K; Oikawa T; Kojima K
    Int J Cancer; 1983 Oct; 32(4):507-14. PubMed ID: 6618710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumorigenicity of intraspecific somatic cell hybrids in nude mice.
    Aden DP; Knowles BB
    J Natl Cancer Inst; 1977 Mar; 58(3):743-6. PubMed ID: 839566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Participation of the H-2 antigens of tumor cells in their lysis by syngeneic T cells.
    Schrader JW; Edelman GM
    J Exp Med; 1976 Mar; 143(3):601-14. PubMed ID: 1082492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement sensitivity of somatic hybrids of a complement-resistant murine leukemia cell line.
    Liang W; Cohen EP
    J Natl Cancer Inst; 1975 Aug; 55(2):309-17. PubMed ID: 51086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors.
    Fortner GW; Kripke ML
    J Immunol; 1977 Apr; 118(4):1483-7. PubMed ID: 66296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Protection afforded by hybrid cells against the inoculation of the parental tumour line (author's transl)].
    Favre R; Filipczyk J; Berebbi M; Meyer G
    Ann Immunol (Paris); 1974; 125(3):491-7. PubMed ID: 4369657
    [No Abstract]   [Full Text] [Related]  

  • 20. Simultaneous development of humoral and cellular tumor-specific immunity against L1210 mouse leukemia.
    Kawashima K; Isobe K; Nagase F; Yokochi T; Nagura E; Hasegawa Y; Morishita H; Yamada K; Nakashima I
    Leuk Res; 1985; 9(7):935-9. PubMed ID: 4021540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.